Skip to main content
Premium Trial:

Request an Annual Quote

Theradiag, Partners Win EC Grant to Develop Rectal Cancer Diagnostic

NEW YORK (GenomeWeb News) – French diagnostics firm Theradiag and its collaborators in South Korea have been awarded a three-year grant from the European Commission to develop tests for rectal cancer based on microRNA and messenger RNA signatures, the company announced yesterday.

Theradiag is working with researchers from the Asan Medical Center and CbsBioscience to validate a set of circulating miRNAs and tissue-based mRNAs as biomarkers of the disease in a study of more than 300 patients, with the goal of combining the tests into a single diagnostic. The partners have been awarded €1.3 million ($1.4 million) for their effort through the EC's Eurostars-2 program, of which Theradiag will receive €300,000.

The Eurostars award "represents another milestone in our development in the field of rectal cancer," Theradiag CEO Michel Finance said in a statement. "It will help strengthen the work already accomplished in this area, and will potentially open up new international markets to us."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.